Principal Securities, Inc. Axsome Therapeutics, Inc. Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 28 shares of AXSM stock, worth $3,407. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 8
250.0%
Holding current value
$3,407
Previous $677,000
331.76%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AXSM
# of Institutions
403Shares Held
37.4MCall Options Held
507KPut Options Held
540K-
Vanguard Group Inc Valley Forge, PA3.95MShares$480 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$402 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$206 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$185 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$138 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.22B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...